Acute Market Reports, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Vietnam. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.
Browse Full Report Visit – http://www.acutemarketreports.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-vietnam
In 2013, Vietnams population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The countrys pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnams medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.
Browse All Reports of This Category – http://www.acutemarketreports.com/category/pharmaceutical-market
The positive trends in Vietnams healthcare market can primarily be attributed to
Increasing coverage of healthcare insurance
Government initiatives to improve healthcare facilities
Scope
This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following
Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, GlaxoSmithKline, AstraZeneca, Novartis and DHG Pharmaceutical JSC
An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
The report will enhance your decision-making capability by allowing you to
Develop business strategies through an understanding of the trends shaping and driving the healthcare market
Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
Identify, understand and capitalize on the opportunities and challenges in the healthcare market
1 Table of Contents7
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 17
2.1 GlobalData Report Guidance 17
3 Overview of the Pharmaceutical and Medical Device Markets 18
3.1 Pharmaceutical Market 18
3.1.1 Market Overview 18
3.1.2 Pharmaceutical Imports and Exports 22
3.1.3 Supply Channels 23
3.1.4 Market Segments 24
3.1.5 Overview of Major Disease Areas 29
3.1.6 Major Players 34
3.2 Medical Device Market 70
3.3 Market Drivers and Barriers 71
3.3.1 Drivers 71
3.3.2 Barriers 73
4 Market Access 75
4.1 Reimbursement and Payer Landscape 75
4.1.1 Overview of Healthcare System 75
4.1.2 Reimbursement Process 76
4.1.3 Overview of Insurance Providers 78
4.1.4 Patient Share in Healthcare Spending 83
4.1.5 Drug Price Trend 84
4.1.6 Pricing Policies 85
4.2 Regulatory Landscape 86
4.2.1 Overview of Regulatory Agencies 86
4.2.2 Market Authorization Procedure for Pharmaceutical Products 86
4.2.3 Licensing Process for Pharmaceutical Manufacturing 93
4.2.4 Licensing Process for Pharmaceutical Exports and Imports 94
4.2.5 Intellectual Property Rights 96
4.2.6 Clinical Trial Regulations 100
4.2.7 Pharmaceutical Advertising Regulations 102
4.2.8 Pharmacy Regulations 104
4.2.9 Labeling and Packaging Regulations 105
Our Blogs :-
http://www.qyresearchreports.net/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
For Technology News : http://www.mobilecomputingtoday.co.uk
Website : http://www.acutemarketreports.com